Sep 14, 2021 / 09:00PM GMT
Andrew Christopher Ranieri - Morgan Stanley, Research Division - Equity Analyst
Thank you, everyone, for joining us today for the 2021 Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the medical device analyst here. It's my pleasure today to have Curt Hartman, President and CEO; and Todd Garner, EVP and CFO of CONMED with us today. Just before we jump into our fireside chat, for important disclosures, please see morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep. So Curt and Todd, thank you so much for being here today. Really appreciate the time.
Questions and Answers:
Andrew Christopher Ranieri - Morgan Stanley, Research Division - Equity AnalystI don't think you'd be surprised with the topic to start. But just given that multiple companies have been talking about at this conference in the past week, the elective surgery impact from Delta, some have pointed to pressure adjusted numbers, but maybe at a high level, what are you seeing in terms of Delta across your orthopedics
Trustpilot
